Primary Menu

Tampa Bay’s Morning Krewe

Weekdays 6:00AM - 10:00AM

A fifth COVID-19 vaccine is in the works from Novavex.

Novavex is launching a phase three trial of their vaccine in the U.S, and they’re looking to Tampa Bay for help.

USF Health and Tampa General Hospital were selected for the testing. They’re hoping to give out shots as early as next week and complete the entire study in the next two to three months.

So 250 volunteers are needed.

They  need all kinds of people – people that are actually at risk either because of personal medical conditions such as people that have obesity cardiovascular issues and diabetes and people that are over the age of 65.

If you are interested, click the link below.

Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico | Novavax Inc. - IR Site

PREVENT-19 will assess the efficacy, safety and immunogenicity of NVX-CoV2373 in the prevention of COVID-19 Trial to enroll up to 30,000 volunteers across approximately 115 sites in the U.S. and Mexico Two-thirds of enrollees to receive active vaccine GAITHERSBURG, Md., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc.